Literature DB >> 32754844

Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.

Pengfei Gu1, Jingyu Deng2, Zhe Sun3, Zhenning Wang3, Wei Wang4, Han Liang5, Huimian Xu6, Zhiwei Zhou7.   

Abstract

PURPOSE: To compare the 8th pN system with ratio-based and Log odds of positive lymph nodes (LODDS) staging systems for predicting the overall survival (OS) of gastric cancer (GC) patients after curative gastric resection.
METHODS: We analyzed, retrospectively, clinicopathologic and prognostic data from three Chinese medical centers, on 7620 patients who underwent curative surgery for GC. We established a hypothetical tumor-LODDS-metastasis (TLM) and tumor-ratio-metastasis (TRM) staging system. The relative discriminative abilities of the different staging systems were assessed using Akaike's Information Criterion (AIC), a linear trend chi-square test, and a likelihood ratio chi-square test.
RESULTS: The cut-off points of the LODDS were set as: ≤ - 1.5, - 1.5 to - 1.0, - 1.0 to - 0.5, - 0.5 to 0, and > 0. There were significant differences in the survival of patients in different LODDS classifications for each pN or LNR group. When stratified by the LODDS classification, the prognosis was more homologous according to the pN or lymph-node ratio (LNR) classifications. The modified TLM staging system had better discriminatory ability and better optimistic prognostic stratification than the 8th TNM or the TRM staging systems for predicting the prognosis of patients with GC.
CONCLUSIONS: The LODDS staging system was superior to other lymph-node classifications for predicting the prognosis of patients undergoing gastrectomy GC. LODDS may be incorporated into a GC staging system if these results are confirmed by other studies.

Entities:  

Keywords:  Gastric cancer; LODDS; Lymph node ratio; Lymph node stage; Prognosis

Mesh:

Year:  2020        PMID: 32754844     DOI: 10.1007/s00595-020-02091-7

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  38 in total

1.  Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.

Authors:  Roderich E Schwarz; David D Smith
Journal:  Ann Surg Oncol       Date:  2006-11-09       Impact factor: 5.344

2.  Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project.

Authors:  Takeshi Sano; Daniel G Coit; Hyung Ho Kim; Franco Roviello; Paulo Kassab; Christian Wittekind; Yuko Yamamoto; Yasuo Ohashi
Journal:  Gastric Cancer       Date:  2016-02-20       Impact factor: 7.370

3.  Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.

Authors:  David D Smith; Rebecca R Schwarz; Roderich E Schwarz
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

4.  Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.

Authors:  Natalie G Coburn; Carol J Swallow; Alex Kiss; Calvin Law
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

5.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

6.  The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer.

Authors:  Jiping Wang; James M Hassett; Merril T Dayton; Mahmoud N Kulaylat
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

7.  Inadequate documentation and resection for gastric cancer in the United States: a preliminary report.

Authors:  N C Estes; J S MacDonald; K Touijer; J Benedetti; J Jacobson
Journal:  Am Surg       Date:  1998-07       Impact factor: 0.688

8.  Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery.

Authors:  B Posteraro; R Persiani; V Dall'Armi; A Biondi; D Arzani; F Sicoli; S Bonassi; D D'Ugo; W Ricciardi; S Boccia
Journal:  Eur J Surg Oncol       Date:  2013-11-12       Impact factor: 4.424

Review 9.  Surgical treatment of advanced gastric cancer: Japanese perspective.

Authors:  M Sasako; M Saka; T Fukagawa; H Katai; T Sano
Journal:  Dig Surg       Date:  2007-04-19       Impact factor: 2.588

10.  Validation of clinical significance of examined lymph node count for accurate prognostic evaluation of gastric cancer for the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system.

Authors:  Jingyu Deng; Jinyuan Liu; Wei Wang; Zhe Sun; Zhenning Wang; Zhiwei Zhou; Huimian Xu; Han Liang
Journal:  Chin J Cancer Res       Date:  2018-10       Impact factor: 5.087

View more
  3 in total

1.  Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.

Authors:  Jian Chen; Yu-Jian Xia; Tian-Yu Liu; Yuan-Hui Lai; Ji-Shang Yu; Tian-Hao Zhang; Shiyin Ooi; Yu-Long He
Journal:  BMC Cancer       Date:  2021-05-10       Impact factor: 4.430

2.  The log odds of positive neck lymph nodes is a superior lymph node predictor for overall survival in head and neck cancer: a population-based analysis in Germany.

Authors:  Mussab Kouka; Elisa Al-Ahmar; Jens Büntzel; Holger Kaftan; Daniel Böger; Andreas Müller; Stefan Schultze-Mosgau; Thomas Ernst; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-11-22       Impact factor: 3.236

3.  Does lymph node ratio (metastasis/total lymph node count) affect survival and prognosis in gastric cancer?

Authors:  Ramazan Topcu; İbrahim T Şahiner; Murat Kendirci; Murathan Erkent; İsmail Sezikli; Mehmet B Tutan
Journal:  Saudi Med J       Date:  2022-02       Impact factor: 1.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.